No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 2qbrA, 1.0000, 0.00, 1.000, 298, 298, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
2, 1ptyA, 0.9983, 0.26, 0.997, 298, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO PHOSPHOTYROSINE MOLECULES
3, 6b8eA, 0.9979, 0.29, 0.993, 298, 298, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 180 K 
4, 1xboA, 0.9978, 0.30, 1.000, 298, 298, PTP1B COMPLEXED WITH ISOXAZOLE CARBOXYLIC ACID
5, 6b90A, 0.9977, 0.31, 1.000, 298, 298, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 100 K (ALTERNATIVE REFINEMENT OF PDB 1SUG SHOWING CONFORMATIONAL HETEROGENEITY) 
6, 3i80A, 0.9977, 0.30, 1.000, 298, 298, PROTEIN TYROSINE PHOSPHATASE 1B - TRANSITION STATE ANALOG FOR THE SECOND CATALYTIC STEP
7, 4i8nA, 0.9975, 0.33, 1.000, 298, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN INHIBITOR [(4-{(2S)-2-(13-BENZOXAZOL-2-YL)-2-[(4-FLUOROPHENYL) SULFAMOYL]ETHYL}PHENYL)AMINO](OXO)ACETIC ACID
8, 1sugA, 0.9973, 0.33, 1.000, 298, 298, 1.95 A STRUCTURE OF APO PROTEIN TYROSINE PHOSPHATASE 1B
9, 1q1mA, 0.9973, 0.33, 1.000, 298, 298, A HIGHLY EFFICIENT APPROACH TO A SELECTIVE AND CELL ACTIVE PTP1B INHIBITORS
10, 6b8tA, 0.9961, 0.40, 0.993, 299, 298, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 240 K 
11, 2zn7A, 0.9960, 0.16, 1.000, 297, 297, CRYSTAL STRUCTURES OF PTP1B-INHIBITOR COMPLEXES
12, 2hb1A, 0.9959, 0.16, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR
13, 2qbsA, 0.9958, 0.18, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
14, 2qbqA, 0.9958, 0.18, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
15, 2azrA, 0.9958, 0.18, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH BICYCLIC THIOPHENE INHIBITOR
16, 2zmmA, 0.9957, 0.20, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
17, 2h4kA, 0.9957, 0.19, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH A MONOCYCLIC THIOPHENE INHIBITOR
18, 2b07A, 0.9957, 0.19, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH TRICYCLIC THIOPHENE INHIBITOR.
19, 2h4gA, 0.9956, 0.20, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B WITH MONOCYCLIC THIOPHENE INHIBITOR
20, 2ntaA, 0.9954, 0.22, 0.997, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
21, 2nt7A, 0.9954, 0.22, 0.997, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
22, 2f70A, 0.9954, 0.22, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
23, 2f6yA, 0.9954, 0.22, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
24, 1aaxA, 0.9954, 0.22, 0.997, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH TWO BIS(PARA-PHOSPHOPHENYL)METHANE (BPPM) MOLECULES
25, 5t19A, 0.9953, 0.23, 1.000, 300, 297, STRUCTURE OF PTP1B COMPLEXED WITH N-(3 -(11-DIOXIDO-4-OXO-125- THIADIAZOLIDIN-2-YL)-4 -METHYL-[11 -BIPHENYL]-4-YL)ACETAMIDE
26, 2qbpA, 0.9953, 0.23, 1.000, 297, 297, CRYSTAL STRUCTURE OF PTP1B-INHIBITOR COMPLEX
27, 2f6wA, 0.9953, 0.23, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
28, 2cm8A, 0.9951, 0.24, 1.000, 297, 297, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
29, 1pa1A, 0.9951, 0.25, 0.997, 302, 297, CRYSTAL STRUCTURE OF THE C215D MUTANT OF PROTEIN TYROSINE PHOSPHATASE 1B
30, 1bzjA, 0.9951, 0.25, 1.000, 297, 297, HUMAN PTP1B COMPLEXED WITH TPICOOH
31, 1eenA, 0.9949, 0.49, 0.997, 299, 298, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-D-A-D-BPA-PTYR-L-I-P-Q-Q-G
32, 2f71A, 0.9948, 0.28, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
33, 2f6zA, 0.9948, 0.28, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
34, 2f6tA, 0.9948, 0.28, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
35, 1ptvA, 0.9948, 0.27, 0.990, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE
36, 2f6vA, 0.9946, 0.29, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH SULFAMIC ACID INHIBITORS
37, 1waxA, 0.9946, 0.28, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B WITH ACTIVE SITE INHIBITOR
38, 1c87A, 0.9946, 0.29, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO-47-DIHYDRO-5H-THIENO[23- C]PYRAN-3-CARBOXYLIC ACID
39, 1l8gA, 0.9942, 0.31, 0.993, 297, 297, CRYSTAL STRUCTURE OF PTP1B COMPLEXED WITH 7-(11-DIOXO-1H- BENZO[D]ISOTHIAZOL-3-YLOXYMETHYL)-2-(OXALYL-AMINO)-47- DIHYDRO-5H-THIENO[23-C]PYRAN-3-CARBOXYLIC ACID
40, 1ecvA, 0.9942, 0.31, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 5-IODO-2-(OXALYL-AMINO)-BENZOIC ACID
41, 1c88A, 0.9940, 0.33, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-4567-TETRAHYDRO- THIENO[23-C]PYRIDINE-3-CARBOXYLIC ACID
42, 1c85A, 0.9940, 0.33, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 2-(OXALYL-AMINO)-BENZOIC ACID
43, 2cniA, 0.9937, 0.55, 1.000, 299, 298, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
44, 1c84A, 0.9936, 0.35, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 3-(OXALYL-AMINO)-NAPHTHALENE-2-CARBOXLIC ACID
45, 2vevA, 0.9935, 0.56, 1.000, 298, 298, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
46, 1c83A, 0.9935, 0.36, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH 6-(OXALYL-AMINO)-1H-INDOLE-5-CARBOXYLIC ACID
47, 1ptuA, 0.9926, 0.41, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING HEXA-PEPTIDE (DADEPYL-NH2)
48, 2bgeA, 0.9919, 0.23, 1.000, 297, 296, STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
49, 6b8xA, 0.9918, 0.44, 0.993, 298, 297, MULTICONFORMER MODEL OF APO WT PTP1B WITH GLYCEROL AT 278 K 
50, 1pttA, 0.9918, 0.45, 0.993, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH PHOSPHOTYROSINE-CONTAINING TETRA-PEPTIDE (AC-DEPYL-NH2)
51, 1c86A, 0.9917, 0.25, 0.986, 296, 296, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (R47V D48N) COMPLEXED WITH 2-(OXALYL-AMINO-47-DIHYDRO-5H- THIENO[23-C]PYRAN-3-CARBOXYLIC ACID
52, 1gfyA, 0.9916, 0.26, 0.980, 296, 296, RESIDUE 259 IS A KEY DETERMINANT OF SUBSTRATE SPECIFICITY OF PROTEIN-TYROSINE PHOSPHATASE 1B AND ALPHA
53, 1g7gA, 0.9913, 0.48, 1.000, 297, 297, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXES WITH PNU179326
54, 5k9wA, 0.9912, 0.29, 1.000, 298, 296, PROTEIN TYROSINE PHOSPHATASE 1B (1-301) IN COMPLEX WITH TCS401 CLOSED STATE
55, 1pxhA, 0.9911, 0.52, 1.000, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B WITH POTENT AND SELECTIVE BIDENTATE INHIBITOR COMPOUND 2
56, 1g1fA, 0.9911, 0.50, 0.997, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A TRI-PHOSPHORYLATED PEPTIDE (RDI(PTR) ETD(PTR)(PTR)RK) FROM THE INSULIN RECEPTOR KINASE
57, 3i7zA, 0.9910, 0.52, 1.000, 297, 297, PROTEIN TYROSINE PHOSPHATASE 1B - TRANSITION STATE ANALOG FOR THE FIRST CATALYTIC STEP
58, 2vexA, 0.9910, 0.52, 1.000, 297, 297, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
59, 4qbwA, 0.9907, 0.70, 1.000, 299, 298, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
60, 4qapA, 0.9907, 0.70, 0.997, 299, 298, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
61, 5ka7A, 0.9905, 0.33, 0.997, 298, 296, PROTEIN TYROSINE PHOSPHATASE 1B T178A MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
62, 3qkqA, 0.9905, 0.33, 0.997, 296, 296, PROTEIN TYROSINE PHOSPHATASE 1B - W179F MUTANT BOUND WITH VANADATE
63, 2veyA, 0.9905, 0.54, 1.000, 297, 297, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
64, 1nweA, 0.9905, 0.34, 0.990, 296, 296, PTP1B R47C MODIFIED AT C47 WITH N-[4-(2-{2-[3-(2-BROMO- ACETYLAMINO)-PROPIONYLAMINO]-3-HYDROXY-PROPIONYLAMINO}- ETHYL)-PHENYL]-OXALAMIC ACID
65, 1g1gA, 0.9905, 0.52, 0.997, 298, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A MONO-PHOSPHORYLATED PEPTIDE (ETDY(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE
66, 1eeoA, 0.9902, 0.56, 0.997, 297, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH ACETYL-E-L-E-F-PTYR-M-D-Y-E-NH2
67, 2cngA, 0.9897, 0.39, 1.000, 296, 296, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
68, 1bzcA, 0.9891, 0.61, 0.993, 297, 297, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH TPI
69, 4zrtA, 0.9890, 0.62, 0.997, 297, 297, PTP1BC215S BOUND TO NEPHRIN PEPTIDE SUBSTRATE
70, 1kavA, 0.9883, 0.62, 1.000, 297, 297, HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
71, 2vewA, 0.9876, 0.52, 1.000, 296, 296, CRYSTAL STRUCUTRE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
72, 2cnfA, 0.9875, 0.53, 1.000, 296, 296, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
73, 2cnhA, 0.9873, 0.54, 1.000, 296, 296, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
74, 2veuA, 0.9872, 0.52, 1.000, 296, 296, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B IN COMPLEX WITH AN ISOTHIAZOLIDINONE-CONTAINING INHIBITOR
75, 1g1hA, 0.9868, 0.65, 0.997, 298, 297, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH A BIS-PHOSPHORYLATED PEPTIDE (ETD(PTR)(PTR) RKGGKGLL) FROM THE INSULIN RECEPTOR KINASE
76, 2cm7A, 0.9867, 0.58, 1.000, 296, 296, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
77, 5ka3A, 0.9866, 0.37, 0.993, 295, 295, PROTEIN TYROSINE PHOSPHATASE 1B YAYA (Y152A Y153A) MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
78, 2cmaA, 0.9865, 0.58, 1.000, 296, 296, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
79, 1kakA, 0.9865, 0.67, 1.000, 297, 297, HUMAN TYROSINE PHOSPHATASE 1B COMPLEXED WITH AN INHIBITOR
80, 4qahA, 0.9852, 0.92, 0.997, 299, 298, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
81, 1g7fA, 0.9835, 0.81, 0.997, 297, 297, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177496
82, 4y14B, 0.9823, 0.42, 1.000, 296, 294, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH INHIBITOR (PTP1B:CPT157633)
83, 2bgdA, 0.9818, 0.24, 1.000, 294, 293, STRUCTURE-BASED DESIGN OF PROTEIN TYROSINE PHOSPHATASE-1B INHIBITORS
84, 4qbeA, 0.9800, 0.93, 0.997, 298, 297, THE SECOND SPHERE RESIDUE T263 IS IMPORTANT FOR FUNCTION AND ACTIVITY OF PTP1B THROUGH MODULATING WPD LOOP
85, 4y14A, 0.9773, 0.51, 1.000, 293, 293, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B COMPLEXED WITH INHIBITOR (PTP1B:CPT157633)
86, 1bzhA, 0.9695, 1.17, 0.993, 297, 297, CYCLIC PEPTIDE INHIBITOR OF HUMAN PTP1B
87, 3qkpA, 0.9636, 0.70, 0.997, 291, 290, PROTEIN TYROSINE PHOSPHATASE 1B - APO W179F MUTANT WITH OPEN WPD-LOOP
88, 2f6fA, 0.9586, 1.59, 0.997, 302, 297, THE STRUCTURE OF THE S295F MUTANT OF HUMAN PTP1B
89, 1a5yA, 0.9460, 0.42, 0.989, 283, 283, PROTEIN TYROSINE PHOSPHATASE 1B CYSTEINYL-PHOSPHATE INTERMEDIATE
90, 5ka9A, 0.9450, 1.57, 0.956, 299, 293, PROTEIN TYROSINE PHOSPHATASE 1B L192A MUTANT IN COMPLEX WITH TCS401 OPEN STATE
91, 1qxkA, 0.9386, 0.62, 1.000, 282, 282, MONOACID-BASED CELL PERMEABLE SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
92, 1q6sA, 0.9375, 0.89, 1.000, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 9
93, 6b95A, 0.9365, 0.93, 0.989, 285, 284, MULTICONFORMER MODEL OF K197C PTP1B TETHERED TO COMPOUND 2 AT 100 K 
94, 1q6nB, 0.9354, 1.00, 0.993, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 4
95, 1q6tA, 0.9349, 0.99, 1.000, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 11
96, 1t48A, 0.9336, 1.41, 0.979, 292, 287, ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
97, 5ka1A, 0.9326, 0.72, 1.000, 284, 281, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
98, 4bjoA, 0.9325, 0.59, 1.000, 285, 280, NITRATE IN THE ACTIVE SITE OF PTP1B IS A PUTATIVE MIMETIC OF THE TRANSITION STATE
99, 6b8zA, 0.9321, 1.25, 0.982, 286, 285, MULTICONFORMER MODEL OF WT PTP1B WITH BB3 AT 273 K 
100, 1lqfB, 0.9318, 0.88, 1.000, 287, 282, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
101, 1q6sB, 0.9314, 1.20, 0.993, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 9
102, 2fjnA, 0.9313, 1.09, 1.000, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
103, 1lqfC, 0.9313, 0.90, 1.000, 287, 282, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
104, 1lqfA, 0.9310, 0.89, 1.000, 287, 282, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
105, 1no6A, 0.9309, 0.90, 0.993, 282, 282, POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 5 USING A LINKED-FRAGMENT STRATEGY
106, 1nz7A, 0.9306, 0.91, 1.000, 282, 282, POTENT SELECTIVE INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B USING A SECOND PHOSPHOTYROSINE BINDING SITE COMPLEXED WITH COMPOUND 19.
107, 1onzA, 0.9304, 0.91, 1.000, 282, 282, OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B COMPOUND 8B
108, 3eaxA, 0.9301, 0.93, 0.996, 282, 282, CRYSTAL STRUCTURE PTP1B COMPLEX WITH SMALL MOLECULE COMPOUND LZP-6
109, 1pynA, 0.9301, 0.92, 0.996, 282, 282, DUAL-SITE POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR USING A LINKED FRAGMENT STRATEGY AND A MALONATE HEAD ON THE FIRST SITE
110, 1nl9A, 0.9299, 0.96, 0.993, 282, 282, POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 12 USING A LINKED-FRAGMENT STRATEGY
111, 1lqfD, 0.9297, 0.96, 1.000, 287, 282, STRUCTURE OF PTP1B IN COMPLEX WITH A PEPTIDIC BISPHOSPHONATE INHIBITOR
112, 1q6pA, 0.9295, 0.97, 0.996, 287, 282, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 6
113, 1q6nA, 0.9295, 1.24, 1.000, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 4
114, 1onyA, 0.9295, 0.93, 1.000, 282, 282, OXALYL-ARYL-AMINO BENZOIC ACID INHIBITORS OF PTP1B COMPOUND 17
115, 1nnyA, 0.9295, 0.97, 0.993, 282, 282, POTENT SELECTIVE PROTEIN TYROSINE PHOSPHATASE 1B INHIBITOR COMPOUND 23 USING A LINKED-FRAGMENT STRATEGY
116, 1ph0A, 0.9287, 0.97, 0.996, 282, 282, NON-CARBOXYLIC ACID-CONTAINING INHIBITOR OF PTP1B TARGETING THE SECOND PHOSPHOTYROSINE SITE
117, 3eb1A, 0.9283, 1.10, 1.000, 283, 283, CRYSTAL STRUCTURE PTP1B COMPLEX WITH SMALL MOLECULE INHIBITOR LZP-25
118, 1nwlA, 0.9280, 1.00, 0.986, 283, 282, CRYSTAL STRUCTURE OF THE PTP1B COMPLEXED WITH SP7343-SP7964 A PTYR MIMETIC
119, 3d9cA, 0.9269, 1.02, 1.000, 282, 282, CRYSTAL STRUCTURE PTP1B COMPLEX WITH ARYL SELENINIC ACID
120, 6baiA, 0.9268, 0.99, 0.982, 282, 282, MULTICONFORMER MODEL OF APO K197C PTP1B AT 100 K 
121, 1q6mA, 0.9268, 1.31, 1.000, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 3
122, 1jf7B, 0.9262, 0.93, 1.000, 281, 281, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836
123, 5kadA, 0.9261, 0.94, 0.996, 285, 280, PROTEIN TYROSINE PHOSPHATASE 1B N193A MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
124, 1q6jA, 0.9249, 1.40, 0.993, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
125, 1q6tB, 0.9248, 1.34, 1.000, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 11
126, 5ka8A, 0.9246, 1.25, 0.986, 289, 283, PROTEIN TYROSINE PHOSPHATASE 1B L192A MUTANT OPEN STATE
127, 1jf7A, 0.9246, 1.02, 1.000, 281, 281, HUMAN PTP1B CATALYTIC DOMAIN COMPLEXED WITH PNU177836
128, 2fjnB, 0.9243, 1.41, 1.000, 289, 284, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
129, 1t49A, 0.9239, 1.02, 0.996, 282, 281, ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
130, 2fjmB, 0.9236, 0.94, 1.000, 285, 280, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
131, 1t4jA, 0.9235, 1.03, 0.996, 282, 281, ALLOSTERIC INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B
132, 3eu0A, 0.9234, 0.93, 1.000, 280, 280, CRYSTAL STRUCTURE OF THE S-NITROSYLATED CYS215 OF PTP1B
133, 3a5jA, 0.9232, 1.05, 0.996, 282, 281, CRYSTAL STRUCTURE OF PROTEIN-TYROSINE PHOSPHATASE 1B
134, 2fjmA, 0.9232, 0.95, 1.000, 285, 280, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 2
135, 1q6pB, 0.9229, 1.27, 0.996, 287, 282, THE STRUCTURE OF PHOSPHOTYROSINE PHOSPHATASE 1B IN COMPLEX WITH COMPOUND 6
136, 5kabA, 0.9228, 1.07, 0.996, 282, 281, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 P185G MUTANT IN COMPLEX WITH TCS401 OPEN STATE
137, 5kadB, 0.9225, 0.70, 0.993, 282, 278, PROTEIN TYROSINE PHOSPHATASE 1B N193A MUTANT IN COMPLEX WITH TCS401 CLOSED STATE
138, 2hnqA, 0.9222, 0.75, 1.000, 278, 278, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B
139, 2cm2A, 0.9221, 1.05, 1.000, 283, 281, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (P212121)
140, 4bjoB, 0.9216, 0.89, 1.000, 286, 279, NITRATE IN THE ACTIVE SITE OF PTP1B IS A PUTATIVE MIMETIC OF THE TRANSITION STATE
141, 5ka2A, 0.9206, 1.05, 0.993, 280, 280, PROTEIN TYROSINE PHOSPHATASE 1B YAYA (Y152A Y153A) MUTANT OPEN STATE
142, 2hnpA, 0.9206, 0.81, 1.000, 278, 278, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE 1B
143, 2b4sA, 0.9206, 1.12, 0.989, 289, 280, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
144, 5ka0A, 0.9201, 1.03, 1.000, 281, 280, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 OPEN STATE
145, 1oetA, 0.9197, 0.95, 1.000, 279, 279, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
146, 1oeoX, 0.9193, 0.96, 1.000, 279, 279, PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO SULFONIC ACID
147, 5ka4A, 0.9191, 1.05, 0.996, 280, 280, PROTEIN TYROSINE PHOSPHATASE 1B T178A MUTANT OPEN STATE
148, 1oevA, 0.9191, 0.97, 1.000, 279, 279, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
149, 1oeuA, 0.9191, 0.96, 1.000, 279, 279, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
150, 2b4sC, 0.9186, 0.92, 0.996, 278, 278, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN PTP1B AND THE INSULIN RECEPTOR TYROSINE KINASE
151, 3a5kA, 0.9183, 1.18, 0.993, 281, 281, CRYSTAL STRUCTURE OF PROTEIN-TYROSINE PHOSPHATASE 1B
152, 5kaaA, 0.9178, 1.10, 0.996, 281, 280, PROTEIN TYROSINE PHOSPHATASE 1B DELTA HELIX 7 P185G MUTANT OPEN STATE
153, 5k9vA, 0.9178, 1.02, 1.000, 279, 279, PROTEIN TYROSINE PHOSPHATASE 1B (1-301) OPEN STATE
154, 3smeA, 0.9175, 1.23, 1.000, 282, 281, STRUCTURE OF PTP1B INACTIVATED BY H2O2/BICARBONATE
155, 5kacA, 0.9169, 1.05, 0.996, 279, 279, PROTEIN TYROSINE PHOSPHATASE 1B P185G MUTANT OPEN STATE
156, 1oesA, 0.9168, 1.25, 1.000, 281, 281, OXIDATION STATE OF PROTEIN TYROSINE PHOSPHATASE 1B
157, 3cweA, 0.9162, 0.83, 0.996, 285, 277, PTP1B IN COMPLEX WITH A PHOSPHONIC ACID INHIBITOR
158, 1i57A, 0.9160, 1.48, 0.996, 284, 284, CRYSTAL STRUCTURE OF APO HUMAN PTP1B (C215S) MUTANT
159, 3zmpA, 0.9150, 0.75, 0.996, 276, 276, SRC-DERIVED PEPTIDE INHIBITOR COMPLEX OF PTP1B
160, 2cmcA, 0.9145, 1.11, 1.000, 285, 279, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
161, 2cneA, 0.9144, 1.12, 1.000, 286, 279, STRUCTURAL INSIGHTS INTO THE DESIGN OF NONPEPTIDIC ISOTHIAZOLIDINONE- CONTAINING INHIBITORS OF PROTEIN TYROSINE PHOSPHATASE 1B
162, 1oemX, 0.9143, 1.24, 1.000, 280, 280, PTP1B WITH THE CATALYTIC CYSTEINE OXIDIZED TO A SULFENYL-AMIDE BOND
163, 2cmbA, 0.9141, 1.12, 1.000, 286, 279, STRUCTURAL BASIS FOR INHIBITION OF PROTEIN TYROSINE PHOSPHATASE 1B BY ISOTHIAZOLIDINONE HETEROCYCLIC PHOSPHONATE MIMETICS
164, 3zv2A, 0.9121, 1.30, 0.993, 280, 280, HUMAN PROTEIN-TYROSINE PHOSPHATASE 1B C215A S216A MUTANT
165, 2cm3B, 0.9027, 0.95, 1.000, 274, 274, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (C2)
166, 2cm3A, 0.9022, 0.96, 1.000, 274, 274, STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE 1B (C2)
167, 3ps5A, 0.8882, 1.97, 0.332, 529, 283, CRYSTAL STRUCTURE OF THE FULL-LENGTH HUMAN PROTEIN TYROSINE PHOSPHATASE SHP-1
168, 1l8kA, 0.8865, 1.44, 0.703, 273, 273, T CELL PROTEIN-TYROSINE PHOSPHATASE STRUCTURE
169, 1larA, 0.8835, 2.11, 0.373, 566, 284, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR
170, 3sr9A, 0.8829, 2.09, 0.370, 568, 284, CRYSTAL STRUCTURE OF MOUSE PTPSIGMA
171, 3zmpB, 0.8818, 0.75, 0.977, 266, 266, SRC-DERIVED PEPTIDE INHIBITOR COMPLEX OF PTP1B
172, 2nlkA, 0.8811, 2.07, 0.336, 553, 283, CRYSTAL STRUCTURE OF D1 AND D2 CATALYTIC DOMAINS OF HUMAN PROTEIN TYROSINE PHOSPHATASE GAMMA (D1+D2 PTPRG)
173, 2fh7A, 0.8792, 2.16, 0.359, 568, 284, CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAINS OF HUMAN PTP SIGMA
174, 4bpcA, 0.8781, 2.12, 0.357, 566, 283, STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE SIGMA IN THE SULFENIC ACID FORM
175, 5xzrA, 0.8757, 1.99, 0.341, 519, 279, THE ATOMIC STRUCTURE OF SHP2 E76A MUTANT IN COMPLEX WITH ALLOSTERIC INHIBITOR 9B
176, 4gwfA, 0.8734, 2.03, 0.341, 497, 279, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
177, 5ehpA, 0.8731, 1.91, 0.347, 494, 277, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
178, 5ehrA, 0.8726, 1.92, 0.347, 485, 277, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
179, 4h1oA, 0.8722, 2.06, 0.344, 496, 279, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH D61G MUTATION
180, 4nwfB, 0.8717, 2.02, 0.345, 496, 278, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
181, 2jjdF, 0.8700, 2.29, 0.333, 542, 282, PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE E ISOFORM
182, 4nwgA, 0.8696, 2.06, 0.342, 498, 278, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
183, 6bmrA, 0.8694, 1.71, 0.350, 489, 274, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
184, 6bmyA, 0.8689, 1.87, 0.345, 480, 275, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
185, 6bmxA, 0.8689, 1.73, 0.350, 488, 274, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
186, 6bmuA, 0.8684, 1.88, 0.345, 480, 275, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
187, 4nwfA, 0.8682, 2.02, 0.343, 489, 277, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH N308D MUTATION
188, 2jjdC, 0.8677, 2.24, 0.336, 541, 280, PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE E ISOFORM
189, 2jjdB, 0.8677, 2.25, 0.336, 541, 280, PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE E ISOFORM
190, 4nwgB, 0.8673, 2.05, 0.343, 492, 277, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH E139D MUTATION
191, 5hdeA, 0.8671, 1.99, 0.329, 299, 277, CRYSTAL STRUCTURE OF PTPN12 CATALYTIC DOMAIN
192, 1yguA, 0.8671, 2.20, 0.323, 558, 279, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP CD45 WITH A PTYR PEPTIDE
193, 5ibmA, 0.8670, 1.76, 0.350, 480, 274, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
194, 1yguB, 0.8670, 2.21, 0.323, 569, 279, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP CD45 WITH A PTYR PEPTIDE
195, 4gwfB, 0.8669, 2.04, 0.339, 493, 277, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Y279C MUTATION
196, 2i1yA, 0.8665, 1.99, 0.359, 287, 276, CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAIN OF HUMAN PTP IA-2
197, 1ygrA, 0.8663, 2.24, 0.319, 561, 279, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAIN OF RPTP CD45
198, 6atdB, 0.8661, 1.77, 0.350, 494, 274, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
199, 4iczA, 0.8656, 2.12, 0.384, 292, 276, HER2 1221/1222 PHOSPHORYLATION REGULATED BY PTPN9
200, 6atdA, 0.8655, 1.88, 0.349, 496, 275, OXIDIZED SHP2 FORMS A DISULFIDE BOND BETWEEN CYS367 AND CYS459 
201, 4dgxA, 0.8654, 1.86, 0.349, 500, 275, LEOPARD SYNDROME-ASSOCIATED SHP2/Y279C MUTANT
202, 2jjdE, 0.8650, 2.27, 0.336, 541, 280, PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE E ISOFORM
203, 2c7sA, 0.8650, 2.19, 0.329, 289, 277, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE KAPPA AT 1.95A RESOLUTION
204, 1ygrB, 0.8650, 2.34, 0.325, 561, 280, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAIN OF RPTP CD45
205, 4dgpA, 0.8646, 1.80, 0.350, 499, 274, THE WILD-TYPE SRC HOMOLOGY 2 (SH2)-DOMAIN CONTAINING PROTEIN TYROSINE PHOSPHATASE-2 (SHP2)
206, 5i6vB, 0.8641, 1.84, 0.347, 496, 274, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
207, 5i6vA, 0.8640, 1.76, 0.348, 488, 273, STRUCTURE OF F285S A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
208, 4ohiA, 0.8639, 1.99, 0.344, 502, 276, LEOPARD SYNDROME-ASSOCIATED SHP2/Q510E MUTANT
209, 5ibsA, 0.8637, 1.76, 0.352, 485, 273, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
210, 4oheA, 0.8636, 1.83, 0.347, 489, 274, LEOPARD SYNDROME-ASSOCIATED SHP2/G464A MUTANT
211, 3brhB, 0.8633, 2.30, 0.333, 296, 279, PROTEIN TYROSINE PHOSPHATASE PTPN-22 (LYP) BOUND TO THE MONO-PHOSPHORYLATED LCK ACTIVE SITE PEPTIDE
212, 3brhA, 0.8633, 2.25, 0.333, 296, 279, PROTEIN TYROSINE PHOSPHATASE PTPN-22 (LYP) BOUND TO THE MONO-PHOSPHORYLATED LCK ACTIVE SITE PEPTIDE
213, 6bmwA, 0.8631, 1.73, 0.349, 475, 272, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504
214, 5ibsB, 0.8630, 1.78, 0.352, 479, 273, STRUCTURE OF E76Q A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
215, 3qcnA, 0.8630, 1.66, 0.351, 286, 271, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 TRIGONAL CRYSTAL FORM
216, 2b3oA, 0.8629, 2.16, 0.332, 504, 277, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE SHP-1
217, 2jjdD, 0.8622, 2.44, 0.333, 539, 282, PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE E ISOFORM
218, 3qcdA, 0.8620, 1.54, 0.353, 283, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH VANADATE TRIGONAL CRYSTAL FORM
219, 3qckA, 0.8619, 2.00, 0.347, 289, 274, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]BENZOIC ACID
220, 3qcgA, 0.8615, 1.69, 0.347, 286, 271, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(3-BROMO-4-CHLOROBENZYL)SULFANYL]THIOPHENE-2- CARBOXYLIC ACID
221, 3qccB, 0.8613, 1.65, 0.352, 285, 270, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH VANADATE ORTHORHOMBIC CRYSTAL FORM
222, 2i1yB, 0.8613, 2.05, 0.360, 290, 275, CRYSTAL STRUCTURE OF THE PHOSPHATASE DOMAIN OF HUMAN PTP IA-2
223, 5ibmB, 0.8612, 1.85, 0.352, 482, 273, STRUCTURE OF S502P A CANCER-ASSOCIATED MUTATION OF THE ONCOGENIC PHOSPHATASE SHP2
224, 3qceA, 0.8612, 1.79, 0.346, 288, 272, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA SOAKING
225, 2qepA, 0.8611, 2.01, 0.369, 288, 274, CRYSTAL STRUCTURE OF THE D1 DOMAIN OF PTPRN2 (IA2BETA)
226, 4qunA, 0.8609, 1.83, 0.344, 283, 273, CRYSTAL STRUCTURE OF THE PTPN3 (PTPH1) CATALYTIC DOMAIN C842S MUTANT
227, 4ri5A, 0.8607, 1.73, 0.346, 284, 272, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E MUTANT IN COMPLEX WITH METAVANADATE
228, 4ohhA, 0.8604, 1.82, 0.344, 494, 273, LEOPARD SYNDROME-ASSOCIATED SHP2/Q506P MUTANT
229, 6bmvA, 0.8602, 1.79, 0.353, 483, 272, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
230, 4ri5B, 0.8602, 1.74, 0.346, 283, 272, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E MUTANT IN COMPLEX WITH METAVANADATE
231, 2h03A, 0.8602, 2.23, 0.373, 288, 276, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
232, 6bmrB, 0.8600, 1.82, 0.349, 481, 272, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP244
233, 2pbnA, 0.8594, 1.60, 0.349, 285, 269, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA
234, 2qepB, 0.8592, 1.94, 0.366, 287, 273, CRYSTAL STRUCTURE OF THE D1 DOMAIN OF PTPRN2 (IA2BETA)
235, 4ge5B, 0.8590, 2.17, 0.380, 299, 276, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 5
236, 2shpB, 0.8588, 1.68, 0.348, 491, 270, TYROSINE PHOSPHATASE SHP-2
237, 4qunB, 0.8587, 1.87, 0.344, 283, 273, CRYSTAL STRUCTURE OF THE PTPN3 (PTPH1) CATALYTIC DOMAIN C842S MUTANT
238, 2shpA, 0.8587, 1.68, 0.348, 491, 270, TYROSINE PHOSPHATASE SHP-2
239, 3qclA, 0.8584, 2.03, 0.344, 289, 273, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]-4-(4-HYDROXYBUT-1-YN-1- YL)BENZOIC ACID
240, 3i36A, 0.8584, 1.91, 0.333, 286, 273, CRYSTAL STRUCTURE OF RAT PROTEIN TYROSINE PHOSPHATASE ETA CATALYTIC DOMAIN
241, 4ge6B, 0.8583, 2.19, 0.377, 304, 276, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 7
242, 6bmyB, 0.8581, 1.85, 0.349, 474, 272, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP844
243, 6bmuB, 0.8580, 1.86, 0.349, 474, 272, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP244
244, 6bmwB, 0.8579, 1.86, 0.349, 473, 272, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITORS SHP099 AND SHP504
245, 4ge2B, 0.8578, 2.20, 0.380, 296, 276, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 3
246, 2g59A, 0.8578, 1.76, 0.351, 287, 271, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE FROM HOMO SAPIENS
247, 6bmvB, 0.8577, 1.86, 0.349, 481, 272, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP504
248, 2pi7A, 0.8577, 1.84, 0.342, 294, 272, STRUCTURE OF THE CATALYTIC DOMAIN OF THE CHICK RETINAL NEURITE INHIBITOR-RECEPTOR PROTEIN TYROSINE PHOSPHATASE CRYP-2/CPTPRO
249, 3zmqA, 0.8576, 0.62, 0.981, 258, 258, SRC-DERIVED MUTANT PEPTIDE INHIBITOR COMPLEX OF PTP1B
250, 4ge5A, 0.8569, 2.25, 0.384, 298, 276, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 5
251, 2jjdA, 0.8568, 2.42, 0.336, 537, 280, PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE E ISOFORM
252, 3qcbB, 0.8565, 1.75, 0.352, 285, 270, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 APO
253, 4hjqA, 0.8564, 1.67, 0.340, 281, 268, SHP-1 CATALYTIC DOMAIN WPD LOOP CLOSED
254, 4ri4A, 0.8563, 1.85, 0.346, 283, 272, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) Y676I MUTANT IN COMPLEX WITH VANADATE
255, 4ge6A, 0.8563, 2.24, 0.380, 303, 276, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 7
256, 2h4vB, 0.8563, 1.65, 0.349, 280, 269, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATASE GAMMA
257, 4ri4B, 0.8561, 1.93, 0.348, 281, 273, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) Y676I MUTANT IN COMPLEX WITH VANADATE
258, 3qccA, 0.8556, 1.62, 0.351, 283, 268, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH VANADATE ORTHORHOMBIC CRYSTAL FORM
259, 5ehpB, 0.8555, 1.74, 0.352, 471, 270, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP836
260, 4ge2A, 0.8555, 2.26, 0.384, 298, 276, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9 (MEG2) COMPLEX WITH COMPOUND 3
261, 6bmxB, 0.8554, 1.85, 0.351, 478, 271, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP844
262, 4hjqB, 0.8554, 1.73, 0.336, 281, 268, SHP-1 CATALYTIC DOMAIN WPD LOOP CLOSED
263, 5j8rA, 0.8553, 2.04, 0.328, 296, 274, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
264, 3qcmB, 0.8553, 2.03, 0.342, 288, 272, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]-4-{[3-({N-[2- (METHYLAMINO)ETHYL]GLYCYL}AMINO)PHENYL]ETHYNYL}BENZOIC ACID
265, 3qciA, 0.8551, 1.88, 0.352, 285, 270, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH N-[(3-AMINOPHENYL)SULFONYL]-3-[(34-DICHLOROBENZYL) SULFANYL]THIOPHENE-2-CARBOXAMIDE
266, 5ehrB, 0.8548, 1.76, 0.352, 470, 270, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 IN COMPLEX WITH ALLOSTERIC INHIBITOR SHP099
267, 2ooqA, 0.8547, 1.58, 0.348, 278, 267, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRT
268, 4grzA, 0.8546, 1.76, 0.338, 282, 269, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH PO4
269, 1wchA, 0.8546, 2.38, 0.332, 308, 277, CRYSTAL STRUCTURE OF PTPL1 HUMAN TYROSINE PHOSPHATASE MUTATED IN COLORECTAL CANCER - EVIDENCE FOR A SECOND PHOSPHOTYROSINE SUBSTRATE RECOGNITION POCKET
270, 4ohlB, 0.8544, 1.71, 0.349, 484, 269, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
271, 2nv5B, 0.8538, 1.71, 0.372, 283, 269, CRYSTAL STRUCTURE OF A C-TERMINAL PHOSPHATASE DOMAIN OF RATTUS NORVEGICUS ORTHOLOG OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D (PTPRD)
272, 2i4gA, 0.8537, 2.41, 0.379, 289, 277, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH A SULFAMIC ACID (SOAKING EXPERIMENT)
273, 4h34A, 0.8536, 2.10, 0.343, 486, 274, CRYSTAL STRUCTURE OF THE TYROSINE PHOSPHATASE SHP-2 WITH Q506P MUTATION
274, 2pa5A, 0.8531, 2.25, 0.385, 296, 275, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9
275, 3qcmA, 0.8530, 2.03, 0.347, 286, 271, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 2-[(34-DICHLOROBENZYL)SULFANYL]-4-{[3-({N-[2- (METHYLAMINO)ETHYL]GLYCYL}AMINO)PHENYL]ETHYNYL}BENZOIC ACID
276, 4ohlA, 0.8528, 1.75, 0.349, 484, 269, LEOPARD SYNDROME-ASSOCIATED SHP2/T468M MUTANT
277, 3qcfA, 0.8528, 1.74, 0.349, 284, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA CO-CRYSTALLIZATION
278, 3qcjA, 0.8526, 1.87, 0.353, 285, 269, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 5-[({3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHEN-2- YL}CARBONYL)SULFAMOYL]-2-METHOXYBENZOIC ACID
279, 3qcbA, 0.8525, 1.67, 0.351, 283, 268, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 APO
280, 3qchA, 0.8523, 1.93, 0.352, 284, 270, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]-N-(METHYLSULFONYL) THIOPHENE-2-CARBOXAMIDE
281, 2ahsA, 0.8521, 2.00, 0.385, 281, 273, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE RECEPTOR PHOSPHATASE BETA
282, 4gfvB, 0.8519, 1.91, 0.324, 288, 272, PTPN18 IN COMPLEX WITH HER2-PY1196 PHOSPHOR-PEPTIDES
283, 4j51B, 0.8516, 2.62, 0.341, 302, 279, CYRSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE LYP CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR INHIBITOR L75N04
284, 2nv5A, 0.8512, 1.76, 0.372, 283, 269, CRYSTAL STRUCTURE OF A C-TERMINAL PHOSPHATASE DOMAIN OF RATTUS NORVEGICUS ORTHOLOG OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D (PTPRD)
285, 2p6xA, 0.8510, 2.64, 0.341, 302, 279, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE PTPN22
286, 4j51A, 0.8509, 2.64, 0.341, 302, 279, CYRSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE LYP CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR INHIBITOR L75N04
287, 5j8rB, 0.8505, 1.92, 0.332, 293, 271, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
288, 2ooqB, 0.8502, 1.65, 0.352, 281, 267, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRT
289, 2h4vA, 0.8500, 1.66, 0.352, 278, 267, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATASE GAMMA
290, 4qumA, 0.8499, 1.92, 0.343, 280, 271, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH A DUALLY PHOSPHORYLATED MAPK12 PEPTIDE
291, 4ohdA, 0.8497, 2.12, 0.339, 494, 274, LEOPARD SYNDROME-ASSOCIATED SHP2/A461T MUTANT
292, 2h02B, 0.8496, 2.09, 0.379, 283, 272, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
293, 3h2xA, 0.8491, 2.61, 0.339, 302, 280, CRYSTAL STRUCTURE OF THE HUMAN LYMPHOID TYROSINE PHOSPHATASE CATALYTIC DOMAIN
294, 1rpmB, 0.8490, 1.74, 0.345, 278, 267, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU DOMAIN 1
295, 1rpmA, 0.8490, 1.74, 0.345, 278, 267, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE MU DOMAIN 1
296, 3olrA, 0.8488, 2.40, 0.342, 297, 275, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
297, 2nv5C, 0.8486, 1.80, 0.372, 283, 269, CRYSTAL STRUCTURE OF A C-TERMINAL PHOSPHATASE DOMAIN OF RATTUS NORVEGICUS ORTHOLOG OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE D (PTPRD)
298, 3olrB, 0.8484, 2.40, 0.342, 297, 275, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
299, 6bn5B, 0.8483, 1.70, 0.352, 448, 267, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2
300, 3olrC, 0.8480, 2.41, 0.342, 297, 275, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
301, 3olrD, 0.8479, 2.40, 0.342, 297, 275, PTPN22 IN COMPLEX WITH CONSENSUS PHOSPHO-TYROSINE PEPTIDE 1
302, 5awxA, 0.8477, 1.75, 0.351, 283, 268, CRYSTAL STRUCTURE OF HUMAN PTPRZ D1 DOMAIN
303, 4s0gA, 0.8476, 1.93, 0.343, 279, 271, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 P850V PEPTIDE
304, 3omhA, 0.8476, 2.39, 0.342, 294, 275, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
305, 3omhC, 0.8473, 2.40, 0.345, 294, 275, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
306, 2p6xB, 0.8471, 2.70, 0.341, 296, 279, CRYSTAL STRUCTURE OF HUMAN TYROSINE PHOSPHATASE PTPN22
307, 3s3eB, 0.8470, 1.81, 0.357, 285, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER
308, 2pi7B, 0.8468, 1.93, 0.341, 289, 270, STRUCTURE OF THE CATALYTIC DOMAIN OF THE CHICK RETINAL NEURITE INHIBITOR-RECEPTOR PROTEIN TYROSINE PHOSPHATASE CRYP-2/CPTPRO
309, 3omhB, 0.8467, 2.07, 0.335, 291, 272, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
310, 2i3rA, 0.8467, 2.05, 0.391, 286, 271, ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA
311, 4rh5A, 0.8465, 2.05, 0.342, 280, 272, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) IN COMPLEX WITH EPS15 PTYR849 PEPTIDE
312, 4rh9A, 0.8462, 2.18, 0.348, 282, 273, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) H812F M883G MUTANT IN COMPLEX WITH EPS15 PTYR849 PEPTIDE
313, 4gfvA, 0.8462, 1.83, 0.323, 286, 269, PTPN18 IN COMPLEX WITH HER2-PY1196 PHOSPHOR-PEPTIDES
314, 3s3hB, 0.8458, 1.83, 0.357, 285, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A PHOSPHOPEPTIDE SUBSTRATE GP4
315, 4rhgA, 0.8457, 2.19, 0.341, 282, 273, CRYSTAL STRUCTURE OF PTPN3 (PTPH1) D811E C842S MUTANT IN COMPLEX WITH EPS15 PTYR849 PEPTIDE
316, 3s3fB, 0.8456, 1.83, 0.357, 285, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULE INHIBITOR VANADATE
317, 3s3hA, 0.8453, 1.85, 0.357, 287, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A PHOSPHOPEPTIDE SUBSTRATE GP4
318, 3s3eA, 0.8453, 1.85, 0.357, 287, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER
319, 2gjtA, 0.8453, 2.26, 0.350, 295, 274, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRO
320, 1larB, 0.8453, 1.95, 0.301, 533, 269, CRYSTAL STRUCTURE OF THE TANDEM PHOSPHATASE DOMAINS OF RPTP LAR
321, 3s3kB, 0.8452, 1.84, 0.357, 285, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULAR INHIBITOR PARA-NITROCATECHOL SULPHATE
322, 3s3fA, 0.8451, 1.86, 0.357, 287, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULE INHIBITOR VANADATE
323, 3qcfB, 0.8451, 1.96, 0.351, 284, 268, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA CO-CRYSTALLIZATION
324, 3qceB, 0.8449, 1.97, 0.351, 284, 268, HUMAN RECEPTOR PROTEIN TYROSINE PHOSPHATASE GAMMA DOMAIN 1 IN COMPLEX WITH 3-[(34-DICHLOROBENZYL)SULFANYL]THIOPHENE-2-CARBOXYLIC ACID VIA SOAKING
325, 2pa5B, 0.8446, 2.17, 0.369, 291, 271, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN9
326, 3s3kA, 0.8445, 1.86, 0.357, 287, 269, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PTP10D FROM DROSOPHILA MELANOGASTER WITH A SMALL MOLECULAR INHIBITOR PARA-NITROCATECHOL SULPHATE
327, 2i4eA, 0.8439, 2.01, 0.390, 281, 269, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
328, 4nndA, 0.8436, 1.82, 0.332, 283, 268, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
329, 2bzlA, 0.8433, 2.01, 0.333, 284, 270, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE N14 AT 1.65 A RESOLUTION
330, 2i75A, 0.8432, 1.75, 0.375, 273, 267, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE N4 (PTPN4)
331, 2i5xA, 0.8431, 1.94, 0.392, 280, 268, ENGINEERING THE PTPBETA CATALYTIC DOMAIN WITH IMPROVED CRYSTALLIZATION PROPERTIES
332, 2h04A, 0.8431, 1.99, 0.384, 280, 268, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
333, 3omhD, 0.8430, 2.43, 0.342, 294, 275, CRYSTAL STRUCTURE OF PTPN22 IN COMPLEX WITH SKAP-HOM PTYR75 PEPTIDE
334, 2i5xB, 0.8422, 2.06, 0.390, 281, 269, ENGINEERING THE PTPBETA CATALYTIC DOMAIN WITH IMPROVED CRYSTALLIZATION PROPERTIES
335, 4nndB, 0.8418, 1.87, 0.332, 283, 268, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
336, 6bn5A, 0.8409, 1.65, 0.352, 448, 264, NON-RECEPTOR PROTEIN TYROSINE PHOSPHATASE SHP2 F285S IN COMPLEX WITH ALLOSTERIC INHIBITOR JLR-2
337, 1yfoB, 0.8402, 1.65, 0.352, 279, 264, RECEPTOR PROTEIN TYROSINE PHOSPHATASE ALPHA DOMAIN 1 FROM MOUSE
338, 1yfoA, 0.8401, 1.73, 0.351, 279, 265, RECEPTOR PROTEIN TYROSINE PHOSPHATASE ALPHA DOMAIN 1 FROM MOUSE
339, 4nndD, 0.8394, 1.85, 0.337, 281, 267, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
340, 5j8rC, 0.8393, 1.96, 0.332, 286, 268, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
341, 2i4eB, 0.8391, 2.07, 0.392, 280, 268, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
342, 5h08A, 0.8387, 1.88, 0.357, 282, 266, HUMAN PTPRZ D1 DOMAIN COMPLEXED WITH NAZ2329
343, 2hc1A, 0.8378, 2.51, 0.380, 288, 274, ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA.
344, 5j8rD, 0.8375, 2.02, 0.332, 284, 268, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 12 - K61R MUTANT
345, 2h02A, 0.8370, 1.90, 0.395, 278, 266, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
346, 2qctB, 0.8369, 2.41, 0.353, 285, 272, STRUCTURE OF LYP WITH INHIBITOR I-C11
347, 2oc3A, 0.8357, 1.79, 0.332, 279, 265, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 18
348, 2hy3B, 0.8353, 1.46, 0.354, 270, 260, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA IN COMPLEX WITH VANADATE
349, 2gjtB, 0.8352, 1.91, 0.346, 277, 266, CRYSTAL STRUCTURE OF THE HUMAN RECEPTOR PHOSPHATASE PTPRO
350, 2hy3A, 0.8351, 1.57, 0.349, 270, 261, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE RECEPTOR PHOSPHATE GAMMA IN COMPLEX WITH VANADATE
351, 2hc2A, 0.8351, 2.13, 0.390, 283, 269, ENGINEERED PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN
352, 2i4hA, 0.8342, 2.33, 0.383, 280, 269, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN CO-CRYSTALLIZED WITH A SULFAMIC ACID INHIBITOR
353, 4nndG, 0.8321, 1.82, 0.333, 278, 264, STRUCTURAL BASIS OF PTPN18 FINGERPRINT ON DISTINCT HER2 TYROSINE PHOSPHORYLATION SITES
354, 2i3rB, 0.8302, 2.13, 0.393, 278, 267, ENGINEERED CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE HPTPBETA
355, 2qcjB, 0.8281, 2.17, 0.345, 280, 267, NATIVE STRUCTURE OF LYP
356, 2qcjA, 0.8268, 2.19, 0.348, 280, 267, NATIVE STRUCTURE OF LYP
357, 2qctA, 0.8258, 2.03, 0.341, 282, 264, STRUCTURE OF LYP WITH INHIBITOR I-C11
358, 3zm3A, 0.8257, 1.90, 0.360, 267, 261, CATALYTIC DOMAIN OF HUMAN SHP2
359, 2a8bA, 0.8251, 2.35, 0.311, 283, 270, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE PHOSPHATASE RECEPTOR TYPE R
360, 2ahsB, 0.8229, 2.18, 0.385, 272, 265, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF HUMAN TYROSINE RECEPTOR PHOSPHATASE BETA
361, 4az1A, 0.8225, 2.39, 0.245, 294, 269, CRYSTAL STRUCTURE OF THE TRYPANOSOMA CRUZI PROTEIN TYROSINE PHOSPHATASE TCPTP1 A POTENTIAL THERAPEUTIC TARGET FOR CHAGAS  DISEASE
362, 4hjpA, 0.8215, 2.29, 0.352, 281, 264, SHP-1 CATALYTIC DOMAIN WPD LOOP OPEN
363, 1jlnA, 0.8211, 2.45, 0.304, 297, 270, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE PTP-SL/BR7
364, 3zm2A, 0.8208, 1.75, 0.360, 263, 258, CATALYTIC DOMAIN OF HUMAN SHP2
365, 4az1B, 0.8193, 2.39, 0.245, 292, 269, CRYSTAL STRUCTURE OF THE TRYPANOSOMA CRUZI PROTEIN TYROSINE PHOSPHATASE TCPTP1 A POTENTIAL THERAPEUTIC TARGET FOR CHAGAS  DISEASE
366, 2qdpA, 0.8170, 2.44, 0.328, 292, 268, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S MUTANT CRYSTALLIZED IN AMMONIUM ACETATE
367, 4gfuA, 0.8166, 1.74, 0.341, 268, 258, PTPN18 IN COMPLEX WITH HER2-PY1248 PHOSPHOR-PEPTIDES
368, 3zm0A, 0.8162, 1.72, 0.367, 261, 256, CATALYTIC DOMAIN OF HUMAN SHP2
369, 2nz6A, 0.8161, 1.80, 0.337, 296, 258, CRYSTAL STRUCTURE OF THE PTPRJ INACTIVATING MUTANT C1239S
370, 3m4uA, 0.8155, 2.30, 0.277, 285, 267, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI PROTEIN TYROSINE PHOSPHATASE TBPTP1
371, 3o4sA, 0.8131, 2.66, 0.327, 293, 269, CRYSTAL STRUCTURE OF HEPTP WITH A CLOSED WPD LOOP AND AN ORDERED E- LOOP
372, 4pvgA, 0.8126, 1.76, 0.367, 264, 256, CRYSTAL STRUCTURE OF PROTEIN TYROSINE PHOSPHATASE SHP2 CATALYTIC DOMAIN COMPLEX WITH SMALL MOLECULAR COMPOUND L88N79
373, 4gs0A, 0.8115, 1.99, 0.359, 279, 256, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH JAK1 ACTIVATION LOOP PEPTIDE
374, 2g59B, 0.8115, 2.39, 0.347, 282, 265, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE FROM HOMO SAPIENS
375, 4ikcA, 0.8100, 1.89, 0.317, 274, 259, CRYSTAL STRUCTURE OF CATALYTIC DOMAIN OF PTPRQ
376, 1fprA, 0.8100, 2.50, 0.348, 284, 264, CRYSTAL STRUCTURE OF THE COMPLEX FORMED BETWEEN THE CATALYTIC DOMAIN OF SHP-1 AND AN IN VITRO PEPTIDE SUBSTRATE PY469 DERIVED FROM SHPS-1.
377, 3zm1A, 0.8090, 1.73, 0.366, 259, 254, CATALYTIC DOMAIN OF HUMAN SHP2
378, 2b49A, 0.8080, 1.65, 0.366, 259, 254, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF PROTEIN TYROSINE PHOSPHATASE NON-RECEPTOR TYPE 3
379, 3m4uB, 0.8078, 2.29, 0.277, 283, 264, CRYSTAL STRUCTURE OF TRYPANOSOMA BRUCEI PROTEIN TYROSINE PHOSPHATASE TBPTP1
380, 3d42A, 0.8070, 2.54, 0.328, 289, 265, CRYSTAL STRUCTURE OF HEPTP IN COMPLEX WITH A MONOPHOSPHORYLATED ERK2 PEPTIDE
381, 4gs0B, 0.8066, 1.68, 0.361, 258, 252, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH JAK1 ACTIVATION LOOP PEPTIDE
382, 2gp0A, 0.8066, 2.42, 0.330, 288, 264, HEPTP CATALYTIC DOMAIN (RESIDUES 44-339) S225D MUTANT
383, 1zc0A, 0.8058, 2.38, 0.331, 286, 263, CRYSTAL STRUCTURE OF HUMAN HEMATOPOIETIC TYROSINE PHOSPHATASE (HEPTP) CATALYTIC DOMAIN
384, 2bv5A, 0.8048, 2.57, 0.302, 281, 268, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 AT 1.8A RESOLUTION
385, 5ovxA, 0.8041, 2.60, 0.306, 286, 268, X-RAY CHARACTERIZATION OF STRIATAL-ENRICHED PROTEIN TYROSINE PHOSPHATASE INHIBITORS
386, 2i3uA, 0.8038, 2.43, 0.380, 276, 263, STRUCTURAL STUDIES OF PROTEIN TYROSINE PHOSPHATASE BETA CATALYTIC DOMAIN IN COMPLEX WITH INHIBITORS
387, 5ovrA, 0.8035, 2.61, 0.306, 286, 268, X-RAY CHARACTERIZATION OF STRIATAL-ENRICHED PROTEIN TYROSINE PHOSPHATASE INHIBITORS
388, 1gwzA, 0.8026, 2.04, 0.357, 280, 255, CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTEIN TYROSINE PHOSPHATASE SHP-1
389, 3d44A, 0.8022, 2.51, 0.323, 284, 263, CRYSTAL STRUCTURE OF HEPTP IN COMPLEX WITH A DUALLY PHOSPHORYLATED ERK2 PEPTIDE MIMETIC
390, 2qdmA, 0.8014, 2.56, 0.316, 286, 263, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S/D236A/Q314A MUTANT
391, 2hvlA, 0.8012, 2.34, 0.326, 285, 261, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN C270S MUTANT
392, 2bijA, 0.8002, 2.55, 0.308, 284, 266, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP STRIATUM ENRICHED ENRICHED PHOSPHATASE)
393, 2qdcA, 0.7993, 2.39, 0.322, 284, 261, CRYSTAL STRUCTURE OF THE HEPTP CATALYTIC DOMAIN D236A MUTANT
394, 3b7oA, 0.7989, 2.04, 0.374, 272, 254, CRYSTAL STRUCTURE OF THE HUMAN TYROSINE PHOSPHATASE SHP2 (PTPN11) WITH AN ACCESSIBLE ACTIVE SITE
395, 4rddA, 0.7987, 1.92, 0.372, 267, 253, CO-CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A CEFSULODIN DERIVATIVE
396, 5ow1A, 0.7961, 2.56, 0.306, 283, 265, X-RAY CHARACTERIZATION OF STRIATAL-ENRICHED PROTEIN TYROSINE PHOSPHATASE INHIBITORS
397, 4gryA, 0.7952, 2.30, 0.340, 271, 256, CRYSTAL STRUCTURE OF SHP1 CATALYTIC DOMAIN WITH SO4
398, 3o5xA, 0.7919, 1.77, 0.373, 255, 249, CRYSTAL STRUCTURE OF THE ONCOGENIC TYROSINE PHOSPHATASE SHP2 COMPLEXED WITH A SALICYLIC ACID-BASED SMALL MOLECULE INHIBITOR
399, 3mowA, 0.7883, 1.80, 0.379, 254, 248, CRYSTAL STRUCTURE OF SHP2 IN COMPLEX WITH A TAUTOMYCETIN ANALOG TTN D- 2 1
400, 3o4tA, 0.7829, 2.54, 0.331, 281, 257, CRYSTAL STRUCTURE OF HEPTP WITH AN OPEN WPD LOOP AND PARTIALLY DEPLETED ACTIVE SITE
401, 2cjzA, 0.7756, 2.55, 0.304, 275, 257, CRYSTAL STRUCTURE OF THE C472S MUTANT OF HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN5 (STEP STRIATUM ENRICHED PHOSPHATASE) IN COMPLEX WITH PHOSPHOTYROSINE
402, 3o4uA, 0.7754, 2.50, 0.331, 276, 254, CRYSTAL STRUCTURE OF HEPTP WITH AN ATYPICALLY OPEN WPD LOOP
403, 2a3kA, 0.7731, 2.30, 0.323, 272, 251, CRYSTAL STRUCTURE OF THE HUMAN PROTEIN TYROSINE PHOSPHATASE PTPN7 (HEPTP HEMATOPOIETIC PROTEIN TYROSINE PHOSPHATASE)
404, 1p15B, 0.7613, 1.91, 0.351, 246, 242, CRYSTAL STRUCTURE OF THE D2 DOMAIN OF RPTPA
405, 1p15A, 0.7536, 1.98, 0.353, 245, 241, CRYSTAL STRUCTURE OF THE D2 DOMAIN OF RPTPA
406, 2cfvA, 0.7501, 1.64, 0.339, 268, 236, CRYSTAL STRUCTURE OF HUMAN PROTEIN TYROSINE PHOSPHATASE RECEPTOR TYPE J
407, 1xxpA, 0.7412, 3.01, 0.158, 287, 253, YERSINIA YOPH (RESIDUES 163-468) C403S BINDS PHOSPHOTYROSYL PEPTIDE AT TWO SITES
408, 1ytwA, 0.7397, 2.94, 0.163, 283, 251, YERSINIA PTPASE COMPLEXED WITH TUNGSTATE
409, 2i42A, 0.7395, 2.84, 0.164, 282, 250, CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE COMPLEXED WITH VANADATE A TRANSITION STATE ANALOGUE
410, 1lyvA, 0.7395, 2.92, 0.159, 283, 251, HIGH-RESOLUTION STRUCTURE OF THE CATALYTICALLY INACTIVE YERSINIA TYROSINE PHOSPHATASE C403A MUTANT IN COMPLEX WITH PHOSPHATE.
411, 3bm8A, 0.7394, 2.76, 0.165, 282, 249, CRYSTAL STRUCTURE OF YOPH MUTANT D356A COMPLEXED WITH IRREVERSIBLE INHIBITOR PVSN
412, 1ytnA, 0.7393, 2.94, 0.163, 283, 251, HYDROLASE
413, 1xxpB, 0.7388, 2.91, 0.159, 283, 251, YERSINIA YOPH (RESIDUES 163-468) C403S BINDS PHOSPHOTYROSYL PEPTIDE AT TWO SITES
414, 3bluA, 0.7387, 2.84, 0.164, 282, 250, CRYSTAL STRUCTURE YOPH COMPLEXED WITH INHIBITOR PVS
415, 3u96B, 0.7381, 2.85, 0.168, 282, 250, CRYSTAL STRUCTURE OF YOPHQ357F(CATALYTIC DOMAIN RESIDUES 163-468) IN COMPLEX WITH PNCS
416, 1xxvB, 0.7381, 2.79, 0.165, 282, 249, YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE CONTAINING HEXAPEPTIDE AT TWO SITES
417, 1xxvA, 0.7380, 2.79, 0.165, 282, 249, YERSINIA YOPH (RESIDUES 163-468) BINDS PHOSPHONODIFLUOROMETHYL-PHE CONTAINING HEXAPEPTIDE AT TWO SITES
418, 3bltA, 0.7377, 2.79, 0.165, 282, 249, CRYSTAL STRUCTURES OF YOPH COMPLEXED WITH PVSN AND PVS INHIBITORS OF YOPH WHICH CO-VALENT BIND TO CYS OF ACTIVE SITE
419, 2yduA, 0.7375, 2.87, 0.164, 282, 250, CRYSTAL STRUCTURE OF YOPH IN COMPLEX WITH 3-(11-DIOXIDO-3-OXOISOTHIAZOLIDIN-5-YL)BENZALDEYDE
420, 1pa9A, 0.7375, 2.96, 0.163, 279, 251, YERSINIA PROTEIN-TYROSINE PHOSPHATASE COMPLEXED WITH PNCS (YOP51PASTEURELLA XPTPASEYOP51DELTA162) (CATALYTIC DOMAIN RESIDUES 163-468) MUTANT WITH CYS 235 REPLACED BY ARG (C235R)
421, 2y2fA, 0.7370, 2.87, 0.164, 282, 250, CRYSTAL STRUCTURE OF YERSINIA PESTIS YOPH IN COMPLEX WITH AN AMINOOXY-CONTAINING PLATFORM COMPOUND FOR INHIBITOR DESIGN
422, 1qz0B, 0.7363, 2.88, 0.164, 282, 250, CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE
423, 1qz0A, 0.7363, 2.88, 0.164, 282, 250, CRYSTAL STRUCTURE OF THE YERSINIA PESTIS PHOSPHATASE YOPH IN COMPLEX WITH A PHOSPHOTYROSYL MIMETIC-CONTAINING HEXAPEPTIDE
424, 3f9aA, 0.7333, 2.90, 0.160, 282, 250, W354F YERSINIA ENTEROCOLITICA PTPASE COMPLEXED WITH TUNGSTATE
425, 4zn5A, 0.7329, 2.91, 0.160, 282, 250, YOPH W354Y YERSINIA ENTEROCOLITICA PTPASE BOND WITH DIVANADATE GLYCEROL ESTER IN THE ACTIVE SITE
426, 4yaaA, 0.7326, 2.92, 0.160, 282, 250, YOPH W354Y YERSINIA ENTEROCOLITICA PTPASE APO FORM
427, 3f9bA, 0.7326, 2.92, 0.160, 282, 250, W354F YERSINIA ENTEROCOLITICA PTPASE COMPLEXED WITH DIVANADATE
428, 4zi4A, 0.7325, 2.92, 0.160, 282, 250, YOPH W354H YERSINIA ENTEROCOLITICA PTPASE BOND WITH DIVANADATE GLYCEROL ESTER IN THE ACTIVE SITE
429, 3u96A, 0.7320, 2.94, 0.168, 282, 250, CRYSTAL STRUCTURE OF YOPHQ357F(CATALYTIC DOMAIN RESIDUES 163-468) IN COMPLEX WITH PNCS
430, 4z6bA, 0.7317, 2.93, 0.160, 282, 250, YOPH W354H YERSINIA ENTEROCOLITICA PTPASE IN THE APO FORM
431, 3f99A, 0.7315, 2.94, 0.160, 282, 250, W354F YERSINIA ENTEROCOLITICA PTPASE APO FORM
432, 1yptB, 0.7291, 2.79, 0.166, 280, 247, CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE AT 2.5 ANGSTROMS AND THE COMPLEX WITH TUNGSTATE
433, 1ytsA, 0.7270, 2.76, 0.163, 278, 245, A LIGAND-INDUCED CONFORMATIONAL CHANGE IN THE YERSINIA PROTEIN TYROSINE PHOSPHATASE
434, 1yptA, 0.7226, 2.81, 0.167, 278, 245, CRYSTAL STRUCTURE OF YERSINIA PROTEIN TYROSINE PHOSPHATASE AT 2.5 ANGSTROMS AND THE COMPLEX WITH TUNGSTATE
435, 1g4wR, 0.6989, 2.29, 0.135, 341, 229, CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP
436, 1g4uS, 0.6822, 2.24, 0.140, 360, 222, CRYSTAL STRUCTURE OF THE SALMONELLA TYROSINE PHOSPHATASE AND GTPASE ACTIVATING PROTEIN SPTP BOUND TO RAC1
437, 5xw4A, 0.5191, 3.67, 0.168, 368, 184, CRYSTAL STRUCTURE OF BUDDING YEAST CDC14P (WILD TYPE) IN THE APO STATE
438, 5xw4B, 0.5187, 3.68, 0.168, 369, 184, CRYSTAL STRUCTURE OF BUDDING YEAST CDC14P (WILD TYPE) IN THE APO STATE
439, 5xw5B, 0.5185, 3.72, 0.163, 364, 184, CRYSTAL STRUCTURE OF BUDDING YEAST CDC14P (C283S) BOUND TO A SWI6P PHOSPHOPEPTIDE
440, 5xw5A, 0.5175, 3.71, 0.174, 362, 184, CRYSTAL STRUCTURE OF BUDDING YEAST CDC14P (C283S) BOUND TO A SWI6P PHOSPHOPEPTIDE
441, 3f41A, 0.5102, 4.67, 0.099, 590, 202, STRUCTURE OF THE TANDEMLY REPEATED PROTEIN TYROSINE PHOSPHATASE LIKE PHYTASE FROM MITSUOKELLA MULTACIDA
442, 4wu3D, 0.5092, 4.61, 0.100, 590, 200, STRUCTURE OF THE PTP-LIKE MYO-INOSITOL PHOSPHATASE FROM MITSUOKELLA MULTACIDA IN COMPLEX WITH MYO-INOSITOL-(1345)-TETRAKISPHOSPHATE
443, 4wu3A, 0.5086, 4.64, 0.085, 590, 199, STRUCTURE OF THE PTP-LIKE MYO-INOSITOL PHOSPHATASE FROM MITSUOKELLA MULTACIDA IN COMPLEX WITH MYO-INOSITOL-(1345)-TETRAKISPHOSPHATE
444, 4wu3C, 0.5078, 4.58, 0.081, 590, 198, STRUCTURE OF THE PTP-LIKE MYO-INOSITOL PHOSPHATASE FROM MITSUOKELLA MULTACIDA IN COMPLEX WITH MYO-INOSITOL-(1345)-TETRAKISPHOSPHATE
445, 3f41B, 0.5076, 4.29, 0.113, 590, 195, STRUCTURE OF THE TANDEMLY REPEATED PROTEIN TYROSINE PHOSPHATASE LIKE PHYTASE FROM MITSUOKELLA MULTACIDA
446, 4wu3B, 0.5072, 4.58, 0.081, 590, 198, STRUCTURE OF THE PTP-LIKE MYO-INOSITOL PHOSPHATASE FROM MITSUOKELLA MULTACIDA IN COMPLEX WITH MYO-INOSITOL-(1345)-TETRAKISPHOSPHATE
447, 3v0hB, 0.5046, 3.02, 0.139, 327, 173, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
448, 1ohcA, 0.5040, 3.54, 0.142, 338, 176, STRUCTURE OF THE PROLINE DIRECTED PHOSPHATASE CDC14
449, 4tvvB, 0.5030, 3.99, 0.124, 288, 185, CRYSTAL STRUCTURE OF LPPA FROM LEGIONELLA PNEUMOPHILA
450, 1oheA, 0.5026, 3.35, 0.138, 338, 174, STRUCTURE OF CDC14B PHOSPHATASE WITH A PEPTIDE LIGAND
451, 1ohdA, 0.5025, 3.34, 0.144, 338, 174, STRUCTURE OF CDC14 IN COMPLEX WITH TUNGSTATE
452, 4tvvC, 0.5021, 3.91, 0.130, 284, 184, CRYSTAL STRUCTURE OF LPPA FROM LEGIONELLA PNEUMOPHILA
453, 3v0dB, 0.5020, 3.49, 0.147, 324, 177, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S)
454, 3v0gD, 0.5015, 3.40, 0.148, 325, 176, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
455, 3v0hA, 0.5011, 3.06, 0.151, 326, 172, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) COMPLEXED WITH D-MYO- INOSITOL-145-TRIPHOSPHATE
456, 3v0gB, 0.5006, 3.36, 0.149, 334, 175, CRYSTAL STRUCTURE OF CIONA INTESTINALIS VOLTAGE SENSOR-CONTAINING PHOSPHATASE (CI-VSP) RESIDUES 241-576(C363S) FORM III
457, 1fq1A, 0.5001, 2.81, 0.163, 183, 172, CRYSTAL STRUCTURE OF KINASE ASSOCIATED PHOSPHATASE (KAP) IN COMPLEX WITH PHOSPHO-CDK2
